147 related articles for article (PubMed ID: 8402119)
1. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients.
Pacelli F; Doglietto GB; Bellantone R; Alfieri S; Sgadari A; Crucitti F
Br J Surg; 1993 Sep; 80(9):1153-6. PubMed ID: 8402119
[TBL] [Abstract][Full Text] [Related]
2. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
4. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
6. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
8. [Feasibility of No.8p lymphadenectomy for the patients with advanced gastric cancer].
Ye Z; Zeng Y; Wei S; Wang Y; Lin Z; Lin Z; Chen X; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1129-1135. PubMed ID: 30370511
[TBL] [Abstract][Full Text] [Related]
9. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan.
Lee WJ; Lee WC; Houng SJ; Shun CT; Houng RL; Lee PH; Chang KJ; Wei TC; Chen KM
World J Surg; 1995; 19(5):707-13. PubMed ID: 7571667
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of gastric adenocarcinoma: the role of lymph node dissection.
Lee WJ; Hsu FC; Shun CT; Lee PH; Yu SC; Chang KJ; Wang SM; Wei TC; Lee WC; Chen KM
J Formos Med Assoc; 1995 May; 94(5):221-7. PubMed ID: 7613253
[TBL] [Abstract][Full Text] [Related]
12. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
13. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic influence of D2 lymphadenectomy with para-aortic lymph nodal dissection for gastric cancer in N3 stage].
Liang YX; Liang H; Ding XW; Wang XN; Zhang L; Wu LL; Liu HG; Jiao XG
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1071-6. PubMed ID: 24499714
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
Wu CW; Hsiung CA; Lo SS; Hsieh MC; Shia LT; Whang-Peng J
Br J Surg; 2004 Mar; 91(3):283-7. PubMed ID: 14991627
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node dissection in gastric cancer.
de Manzoni G; Verlato G; Guglielmi A; Laterza E; Genna M; Cordiano C
Br J Surg; 1996 Nov; 83(11):1604-7. PubMed ID: 9014687
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction.
Mine S; Sano T; Hiki N; Yamada K; Nunobe S; Yamaguchi T
Br J Surg; 2013 Jan; 100(2):261-6. PubMed ID: 23180514
[TBL] [Abstract][Full Text] [Related]
19. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
20. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.
Adachi Y; Suematsu T; Shiraishi N; Tanimura H; Morimoto A; Kitano S
Br J Surg; 1998 Sep; 85(9):1281-4. PubMed ID: 9752878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
